Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

IMPORTANCE: Cardiovascular adverse events (CVAE) with carfilzomib in patients with multiple myeloma can be potentially life-threatening and remain incompletely characterized. We performed the first systematic review and meta-analysis of carfilzomib-associated CVAE. OBJECTIVE: To determine the incide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Waxman, Adam J., Clasen, Suparna, Hwang, Wei-Ting, Garfall, Alfred, Vogl, Dan T., Carver, Joseph, O’Quinn, Rupal, Cohen, Adam D., Stadtmauer, Edward A., Ky, Bonnie, Weiss, Brendan M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885859/
https://ncbi.nlm.nih.gov/pubmed/29285538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.4519
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados